1,3-Bis(4-cyanophenoxy)-4,6-dichlorobenzene | 163301-42-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,3-Bis(4-cyanophenoxy)-4,6-dichlorobenzene
• 英文别名: 4-[2,4-Dichloro-5-(4-cyanophenoxy)phenoxy]benzonitrile
• CAS: 163301-42-6
• 化学式: C₂₀H₁₀Cl₂N₂O₂
• 分子量: 381.218
• InChiKey: ONMMHFGDCDUKSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1,3-Bis(4-cyanophenoxy)-4,6-dichlorobenzene 在 盐酸 、 氨 作用下， 以 乙醇 为溶剂， 反应 18.0h， 生成 4-[5-(4-Carbamimidoylphenoxy)-2,4-dichlorophenoxy]benzenecarboximidamide
  参考文献：
  名称：

  Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors

  摘要：

  A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a K-i for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h Do factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.

  DOI：

  10.1021/jm980667k
• 作为产物：
  描述：

  对氟苯腈 、 4,6-二氯间苯二酚 在 potassium carbonate 作用下， 以 二甲基亚砜 为溶剂， 反应 16.0h， 生成 1,3-Bis(4-cyanophenoxy)-4,6-dichlorobenzene
  参考文献：
  名称：

  Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors

  摘要：

  A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a K-i for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h Do factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.

  DOI：

  10.1021/jm980667k

文献信息

• NOVEL BISOXADIAZOLIDINE DERIVATIVE
  申请人：YAMANOUCHI PHARMACEUTICAL CO. LTD.

  公开号：EP0696585A1

  公开（公告）日：1996-02-14

  A bisoxadiazolidinedione derivative of general formula (I) useful as an insulin-sensitivity improver, a pharmaceutically acceptable salt thereof, and a medicinal composition thereof, wherein (a) and (b) may be the same or different from each other and each represent an optionally substituted phenylene group, and L represents: (1) an oxygen atom, (2) a group of formula (II) (R¹ being a hydrogen atom or a lower alkyl group), (3) a group of the formula: -S(O)n- (n being 0, 1 or 2), (4) a group of the formula: -CO-, (5) a group of formula (III) or (IV) (R² being a hydrogen atom or a lower alkyl group), or (6) an alkylene or alkenylene group which may be substituted and interrupted by an oxygen atom and/or a sulfur atom, and the like.

  一种用作胰岛素敏感性改善剂的通式(I)的双噁二唑烷二酮衍生物、其药学上可接受的盐及其药物组合物，其中(a)和(b)可以相同或互不相同，且各自代表任选取代的亚苯基，L代表：(1) 氧原子，(2) 式 (II) 的基团（R¹ 为氢原子或低级烷基），(3) 式中的基团：-S(O)n-（n 为 0、1 或 2），(4) 式中的一个基团：-CO-，(5)式(III)或(IV)的基团（R²为氢原子或低级烷基），或(6)可被氧原子和/或硫原子取代和间断的亚烷基或烯基等。
• US5643931A
  申请人：——

  公开号：US5643931A

  公开（公告）日：1997-07-01
• Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors
  作者：Gary Phillips、David D. Davey、Keith A. Eagen、Sunil K. Koovakkat、Amy Liang、Howard P. Ng、Michael Pinkerton、Lan Trinh、Marc Whitlow、Alicia M. Beatty、Michael M. Morrissey

  DOI：10.1021/jm980667k

  日期：1999.5.1

  A novel series of 2,6-diphenoxypyridines has been designed to inhibit factor Xa, a serine protease strategically located in the coagulation cascade. The evolution from the photochemically unstable bisamidine (Z,Z)-BABCH to potent bisamidine compounds with a pyridine heterocycle as the core scaffold has been achieved. The most potent compound in the series, 6h, has a K-i for human factor Xa of 12 nM. The selectivity of 6h against bovine trypsin and human thrombin was greater than 90- and 1000-fold, respectively. Two proposed modes of binding of 6h Do factor Xa are made based on the crystal structures of 6h by itself and of 6h bound to bovine trypsin.